Long-Term Efficacy and Complete Scalp Hair Regrowth in Patients With Alopecia Areata Receiving Ritlecitinib 50 mg QD Up to 3 Years in the ALLEGRO Clinical Trial ProgramBrett King, Alexandre Lejeune, Lidia Rudnicka et al.|SKIN The Journal of Cutaneous Medicine|2025Cited by 0